Trends in pediatric donor heart discard rates and the potential use of unallocated hearts for allogeneic valve transplantation.

allogeneic valve transplant heart transplant organ procurement organ shortage valve replacement

Journal

JTCVS open
ISSN: 2666-2736
Titre abrégé: JTCVS Open
Pays: Netherlands
ID NLM: 101768541

Informations de publication

Date de publication:
Sep 2023
Historique:
received: 15 02 2023
revised: 30 05 2023
accepted: 31 05 2023
medline: 9 10 2023
pubmed: 9 10 2023
entrez: 9 10 2023
Statut: epublish

Résumé

Allogeneic valve transplantation is an emerging therapy that delivers a living valve from a donor heart. We reviewed the national discard rate of pediatric and young adult (aged 25 years or younger) donor grafts to estimate the number of hearts potentially available to source valve allotransplantation. We queried the United Network for Organ Sharing database to identify pediatric and young adult heart donors from 1987 to 2022. Donor heart discard was defined as nontransplantation of the allograft. Of 72,460 pediatric/young adult heart donations, 41,065 (56.7%) were transplanted and 31,395 (43.3%) were unutilized. The average annual number of discarded hearts in era 1 (1987-2000), era 2 (2000-2010), and era 3 (2010-2022) was 791 (42.8%), 1035 (46.3%), and 843 (41.2%), respectively. From 2017 to 2021, the average annual number of discards by age was: 39 (31.8%) neonates/infants, 78 (38.0%) toddlers, 41 (49.4%) young children, 240 (38.0%) adolescents, and 498 (40.1%) young adults. High-volume procurement regions had the greatest proportion of nonutilization, with the national average discard rate ranging from 39% to 49%. The most frequently documented reasons for nonallocation were distribution to the heart valve industry (26.5%), presumably due to suboptimal graft function, poor organ function (22.7%), and logistical challenges (10.8%). With ∼900 pediatric/young adult donor hearts discarded annually, unutilized grafts represent a potential source of valves for allogeneic valve transplant to supplement current conduit and valve replacement surgery. The limited availability of neonatal and infant hearts may limit this technique in the youngest patients, for whom cryopreserved homografts or xenografts will likely remain the primary valve substitute.

Identifiants

pubmed: 37808067
doi: 10.1016/j.xjon.2023.06.002
pii: S2666-2736(23)00127-4
pmc: PMC10556831
doi:

Types de publication

Journal Article

Langues

eng

Pagination

374-381

Informations de copyright

© 2023 The Author(s).

Références

J Heart Lung Transplant. 2020 Apr;39(4):331-341
pubmed: 32088108
J Thorac Cardiovasc Surg. 1987 Dec;94(6):812-23
pubmed: 3682851
J Thorac Cardiovasc Surg. 1995 Jul;110(1):186-93; discussion 193-4
pubmed: 7609543
Arch Cardiovasc Dis. 2012 Oct;105(10):517-28
pubmed: 23062483
J Thorac Cardiovasc Surg. 2020 Aug 3;:
pubmed: 32891449
J Card Surg. 2022 Dec;37(12):5307-5312
pubmed: 36259737
J Card Surg. 1987 Mar;2(1 Suppl):185-91
pubmed: 2979970
Ann Thorac Surg. 2019 Jan;107(1):143-150
pubmed: 30267694
Front Surg. 2021 Jul 13;8:676739
pubmed: 34327211
Tex Heart Inst J. 1997;24(3):221-2
pubmed: 9339513

Auteurs

Stephanie N Nguyen (SN)

Section of Pediatric and Congenital Cardiac Surgery, Columbia University Irving Medical Center, New York Presbyterian-Morgan Stanley Children's Hospital, New York, NY.

Alexis Schiazza (A)

Section of Pediatric and Congenital Cardiac Surgery, Columbia University Irving Medical Center, New York Presbyterian-Morgan Stanley Children's Hospital, New York, NY.

Marc E Richmond (ME)

Department of Pediatric Cardiology, Columbia University Irving Medical Center, New York Presbyterian-Morgan Stanley Children's Hospital, New York, NY.

Warren A Zuckerman (WA)

Department of Pediatric Cardiology, Columbia University Irving Medical Center, New York Presbyterian-Morgan Stanley Children's Hospital, New York, NY.

Emile A Bacha (EA)

Section of Pediatric and Congenital Cardiac Surgery, Columbia University Irving Medical Center, New York Presbyterian-Morgan Stanley Children's Hospital, New York, NY.

Andrew B Goldstone (AB)

Section of Pediatric and Congenital Cardiac Surgery, Columbia University Irving Medical Center, New York Presbyterian-Morgan Stanley Children's Hospital, New York, NY.

Classifications MeSH